73 results
Page 3 of 4
424B5
b3nv00frtkkjzmd2 mbc
17 Apr 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
ywidctqn0cvu8o
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
S-3MEF
EX-5.1
rdd s16pea6zrzh
16 Apr 20
Registration of additional securities for an S-3
6:07am
424B5
u1jxznhf x20ncpvi
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
x5qxf4kz
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
424B5
k2ru5br4l8vhf9xnp
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
jo0iwgoasp sz
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
usdipba1x0e03
16 Mar 20
Annual report
11:09am
DEF 14A
225fvbdarz9mxhhl7uc6
1 Oct 19
Definitive proxy
6:07am
8-K
EX-1.1
o6siq4vx
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
h5qdc6ev0qufi
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
424B5
e3ewc 8cjkr
27 Sep 19
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
ognz1un rmmz5z
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
424B5
zzbmdb0du5tw3
5 Aug 19
Prospectus supplement for primary offering
9:08am
8-K
EX-10.1
z4u2lub
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-1.1
2js09nc1k2d
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
424B5
pzb8ykgra k4
2 Aug 19
Prospectus supplement for primary offering
4:28pm
CORRESP
con ibcg2j
25 Jul 19
Correspondence with SEC
12:00am